There was a compelling elevation of the levels of TNF-α, IL-6, and IL-1β in BALF and serum of CLP-induced ALI which were lowered by GPA peptide therapy (Figures 3(a)–3(f)). The gene discussed is IL1B; the disease is acute respiratory distress syndrome.